Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer

Figure 4 A: The 5-year recurrence-free survival rate differed significantly (P = 0. 037) and was 51.9% for strong BAMBI expression compared to 79.8% for weak BAMBI expression; B: The impact of the coexpression of BAMBI and β-catenin on the recurrence-free survival with high β-catenin expression, the 5-year recurrence-free survival was 46.9% for strong BAMBI expression compared to 80.8% for weak BAMBI expression (P = 0.035); C: The impact of the coexpression of BAMBI and p53 on the recurrence-free survival with positive p53 expression, the 5-year recurrence-free survival rate was 43.4% for strong BAMBI expression compared to 78.2% for weak BAMBI expression (P = 0.049).